Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 1,558: | Line 1,558: | ||
| | | | ||
| | | | ||
| − | | | + | |In situ follicular B-cell neoplasm |
|Rachel D. Burnside, PhD, MBA, FACMGG | |Rachel D. Burnside, PhD, MBA, FACMGG | ||
| + | |Pending | ||
| | | | ||
| − | | | + | |Author assigned on 7/28/2023 |
| − | |||
|- | |- | ||
|[[HAEM5:Follicular lymphoma|Follicular lymphoma]] | |[[HAEM5:Follicular lymphoma|Follicular lymphoma]] | ||
| Line 1,670: | Line 1,670: | ||
| | | | ||
| | | | ||
| − | | | + | |NEW (No Prior) |
| − | | | + | |NEW (No Prior) |
| − | | | + | |NEW (No Prior) |
| − | | | + | |NEW (No Prior) |
| − | | | + | |NEW (No Prior) |
|- | |- | ||
|Transformations of indolent B-cell lymphomas | |Transformations of indolent B-cell lymphomas | ||
Revision as of 15:10, 22 December 2023
Welcome!
- For assignments, please see the "Author" column below (3rd column from left). If no name is present, volunteer to create content!
- To volunteer, please [Contact us] with your page of interest.
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Prior Content Status (4th Edition)(Pending or Complete) | Prior Date of Last Editor Review (4th Edition) | Prior Notes (4th Edition) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
||||||||||||
| Clonal haematopoiesis | Disease | Fabiola Quintero-Rivera (FQR) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Clonal cytopenias of undetermined significance | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Chronic myeloid leukaemia | Disease | FQR | Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | Complete | Date page was created | ||||||||
| Chronic neutrophilic leukaemia | Disease | FQR | Chronic Neutrophilic Leukemia (CNL) | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | Complete | Date page was created | ||||||||
| Chronic eosinophilic leukaemia | Disease | FQR | Chronic Eosinophilic Leukemia, Not Otherwise Specified | Chelsea D. Kramish; Daynna J.Wolff | complete/pending faculty review | |||||||||
| Polycythaemia vera | Disease | FQR | Polycythemia Vera (PV) | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | Complete | |||||||||
| Essential thrombocythaemia | Disease | FQR | Essential Thrombocythemia (ET) | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | Complete | |||||||||
| Primary myelofibrosis | Disease | FQR | Primary Myelofibrosis (PMF) | T. Niroshi Senaratne, UCLA | Complete | 8/4/2020 before submission |
||||||||
| Juvenile myelomonocytic leukaemia | Disease | FQR | Juvenile Myelomonocytic Leukemia (JMML) | Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology
Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories |
PENDING importing content and reference formatting | FQR has emailed SR several times, last 4/20/22 | ||||||||
| Myeloproliferative neoplasm, NOS | Disease | FQR | Myeloproliferative Neoplasm (MPN), Unclassifiable | Thomas Lee, MD, PhD, University of California, Los Angeles | Complete | |||||||||
| Cutaneous mastocytosis | Disease | FQR | Cutaneous Mastocytosis | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | Complete | |||||||||
| Systemic mastocytosis | Disease | FQR | Systemic Mastocytosis | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | Complete | |||||||||
| Mast cell sarcoma | Disease | FQR | Mast Cell Sarcoma | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | Complete | |||||||||
| Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | FQR | Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG | Complete | |||||||||
| Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | Eric McGinnis (assigned to new 5th edition page - FQR is this reviewed?) | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
| Myelodysplastic neoplasm with low blasts | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm, hypoplastic | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm with increased blasts | Disease | FQR | Myelodysplastic Syndrome (MDS) with Excess Blasts | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Childhood myelodysplastic neoplasm with low blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Childhood myelodysplastic neoplasm with increased blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Chronic myelomonocytic leukaemia | Disease | FQR | Chronic Myelomonocytic Leukemia (CMML) | Linsheng Zhang, MD, PhD | Complete | |||||||||
| Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | FQR | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Linsheng Zhang, MD, PhD | Complete | |||||||||
| Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | FQR | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | Complete | Date page was created | ||||||||
| Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | FQR | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | Complete | |||||||||
| Acute promyelocytic leukaemia with PML::RARA fusion | Disease | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | Acute Promyelocytic Leukemia (APL) with PML-RARA | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 04/26/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | Jennelle C. Hodge, PhD, FACMG | Complete | 02/24/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with BCR-ABL1 | Kay Weng Choy MBBS, Monash Medical Centre | Complete | |||||||||
| Acute myeloid leukaemia with KMT2A rearrangement | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with MECOM rearrangement | Disease | JH_MS | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | Gordana Raca MD PhD, University of Southern California, Los Angeles | Complete | Need permission for figure? Update WHO? | ||||||||
| Acute myeloid leukaemia with NUP98 rearrangement | Disease | Eric McGinnis, MD | 12/20/23 | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Acute myeloid leukaemia with NPM1 mutation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Mutated NPM1 | Xinjie Xu, PhD, FACMG | Complete | Add WHO reference | ||||||||
| Acute myeloid leukaemia with CEBPA mutation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | Paul Defazio, MSc, Monash Health | Complete | |||||||||
| Acute myeloid leukaemia, myelodysplasia-related | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute myeloid leukaemia with minimal differentiation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Minimal Differentiation | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | Complete | |||||||||
| Acute myeloid leukaemia without maturation | Disease | JH_MS | Acute Myeloid Leukemia (AML) without Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute myeloid leukaemia with maturation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute basophilic leukaemia | Disease | JH_MS | Acute Basophilic Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||||
| Acute myelomonocytic leukaemia | Disease | JH_MS | Acute Myelomonocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute monocytic leukaemia | Disease | JH_MS | Acute Monoblastic and Monocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute erythroid leukaemia | Disease | JH_MS | Pure Erythroid Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||||
| Acute megakaryoblastic leukaemia | Disease | JH_MS | Acute Megakaryoblastic Leukemia (AMKL) | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Myeloid sarcoma | Disease | JH_MS | Myeloid Sarcoma | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | Complete | |||||||||
| RESOLVE 4th edition AML-Related NON-WHO entities content | Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | ISSUE- FIX
|
||||||||||||
| Myeloid neoplasm post cytotoxic therapy | Disease | JH_MS | Therapy-Related Myeloid Neoplasms | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | Complete | Check reference format | ||||||||
| Myeloid neoplasms associated with germline predisposition | Disease | JH_MS | Multiple pages including overview page (Myeloid Neoplasms with Germline Predisposition - Compendium of Cancer Genome Aberrations (ccga.io)) and 6 disease pages ( HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation, HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation, HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation, HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation, HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation, HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation) | See links from instructions on the 5th edition page | Complete | Most were re-reviewed by MS on 03/02/2021 | For page Acute Myeloid Leukaemia with Germline CEBPA Mutation - Note by MS of "Review completed, awaiting some clarification from JH - 07/04/2022" | |||||||
| Myeloid proliferations associated with Down syndrome | Disease | JH_MS | MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | Complete (all three pages) | |||||||||
| Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement | Jay Alden, DO | Complete | |||||||||
| Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | Complete | |||||||||
| Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement | Yanna Ding, MD PhD | Complete | |||||||||
| Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | ISSUE- FIX
|
FQR | Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff | Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff | Complete | ||||||||
| Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | Tracy Tucker, PhD, FCCMG | Complete | |||||||||
| Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | Tracy Tucker, PhD, FCCMG | Complete | |||||||||
| Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia, B/myeloid | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | Complete | |||||||||
| Mixed-phenotype acute leukaemia, T/myeloid | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | Complete | |||||||||
| Mixed-phenotype acute leukaemia, rare types | Disease | JH_MS | Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | PENDING | |||||||||
| Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute undifferentiated leukaemia | Disease | JH_MS | Acute Undifferentiated Leukemia | Amelia Nakanishi, MD and Shashi Shetty, PhD | Complete | Check reference format | ||||||||
| CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
||||||||||||
| Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Blastic plasmacytoid dendritic cell neoplasm | Disease | GC | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hao Liu, MD and Daynna J. Wolff, PhD | Complete | Previously within myeloid section under JH/MS editors | ||||||||
| Langerhans cell histiocytosis | Disease | GC | Langerhans Cell Histiocytosis | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | Complete | 5/19/2022 |
Date completed by author: 04/28/2022 | |||||||
| Langerhans cell sarcoma | Disease | GC | Langerhans Cell Sarcoma | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | Complete | 5/19/2022 |
Date completed by author: 04/28/2022 | |||||||
| Indeterminate dendritic cell tumour | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Interdigitating dendritic cell sarcoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Juvenile xanthogranuloma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Erdheim-Chester disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Rosai-Dorfman Disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| ALK-positive histiocytosis | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Histiocytic sarcoma | Disease | GC | Histiocytic Sarcoma | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | Complete | 10/01/2021 | Date completed by author: 10/01/2021 | |||||||
| CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|
|||||||||||
| Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| IgG4-related disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Unicentric Castleman disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Idiopathic multicentric Castleman disease | Disease | GC | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| KSHV/HHV8-associated multicentric Castleman disease | Disease | GC | Multicentric Castleman Disease | Sudha Arumugam, MD | Complete | 01/24/2022 | Date completed by author: 01/24/2022 | |||||||
| B-lymphoblastic leukaemia/lymphoma | Disease | Holli Drendel (HD) | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified | Holli Drendel | PENDING | |||||||||
| B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | PENDING | |||||||||
| B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | Complete | |||||||||
| B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | Holli authoring - Complete? Looks like needs more editing of tables | HD | B-Lymphoblastic Leukemia/Lymphoma with iAMP21 [but was completed as a 5th edition page by Holli] | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | ?Complete | ||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | PENDING | |||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | Complete | |||||||||
| B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged | Yassmine Akkari Nicolas Millan | PENDING | |||||||||
| B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | HD | B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | PENDING | |||||||||
| B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | PENDING | |||||||||
| B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | HD | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | PENDING | |||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| B-lymphoblastic leukaemia/lymphoma, NOS | Disease | HD | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| RESOLVE 4th edition ALL-Related NON-WHO entities content | B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ISSUE- FIX
|
ISSUE - FIX | |||||||||||
| Monoclonal B-cell lymphocytosis | Disease | Shivani Golem (SG) | Monoclonal B-cell Lymphocytosis | Tsigab Bahta Hagos (trainee) / Shashirekha Shetty | PENDING | Assigned 12/19/2022 with completion date of 1/19/2023 | ||||||||
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | Jaime Nagy, PhD, University of Iowa
Renee Eigsti, MD, Pathology Services of Kalamazoo Honey Reddi, PhD, Belay Diagnostics |
Complete (Shivani, please confirm) | SG | Already converted to 5th edition | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | ||||||||
| Hairy cell leukaemia | Disease | SG | Hairy Cell Leukemia | Snehal Patel, MD, PhD | Complete | |||||||||
| Splenic marginal zone lymphoma | Disease | SG | Splenic Marginal Zone Lymphoma | Snehal Patel, MD, PhD | Complete | |||||||||
| Splenic diffuse red pulp small B-cell lymphoma | Disease | SG | Splenic Diffuse Red Pulp Small B-cell Lymphoma | Snehal Patel, MD, PhD | Complete | |||||||||
| Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | SG | Hairy Cell Leukemia Variant | Snehal Patel, MD, PhD | Complete | |||||||||
| Lymphoplasmacytic lymphoma | Disease | SG | Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia | Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | Complete | 4/12/2023 by FQR | ||||||||
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | SG | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG*
Department of Pathology and Laboratory Medicine and *Pediatrics, School of Medicine, University of California Irvine (UCI) |
Complete | 4/12/23 by FQR | ||||||||
| Primary cutaneous marginal zone lymphoma | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Nodal marginal zone lymphoma | Disease | SG | Nodal Marginal Zone Lymphoma | Andrew Ly, DO and Shivani Golem, PhD, FACMG | Complete | 5/28/2021 | ||||||||
| Paediatric nodal marginal zone lymphoma | Disease | SG | Paediatric Nodal Marginal Zone Lymphoma | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | Complete | 11/11/2020 | ||||||||
| In situ follicular B-cell neoplasm | Disease | SG | In situ follicular B-cell neoplasm | Rachel D. Burnside, PhD, MBA, FACMGG | Pending | Author assigned on 7/28/2023 | ||||||||
| Follicular lymphoma | Disease | SG | Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | |||||||||||
| Paediatric-type follicular lymphoma | Disease | SG | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | |||||||||||
| Duodenal-type follicular lymphoma | Disease | SG | ||||||||||||
| Primary cutaneous follicle centre lymphoma | Disease | SG | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | Complete | 09/10/2022 | |||||||||
| In situ mantle cell neoplasm | Disease | SG | In Situ Mantle Cell Neoplasia | Rina Kansal, MD; Versiti Blood Center of Wisconsin | ||||||||||
| Mantle cell lymphoma | Disease | SG | Mantle Cell Lymphoma | * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | Pending | Target completion date 8/15/20 | ||||||||
| Leukaemic non-nodal mantle cell lymphoma | Disease | SG | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Transformations of indolent B-cell lymphomas | Disease | SG | ||||||||||||
| Diffuse large B-cell lymphoma, NOS | Disease | GC | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | |||||||||||
| T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | ||||||||||||
| Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | GC | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |||||||||||
| ALK-positive large B-cell lymphoma | Disease | GC | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | |||||||||||
| Large B-cell lymphoma with IRF4 rearrangement | Disease | GC | *Afia Hasnain, MBBS, PhD | |||||||||||
| High grade B-cell lymphoma with 11q aberrations | Disease | GC | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | |||||||||||
| Lymphomatoid granulomatosis | Disease | GC | ||||||||||||
| EBV-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
| Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | ||||||||||||
| Fibrin-associated large B-cell lymphoma | Disease | GC | ||||||||||||
| Fluid overload-associated large B-cell lymphoma | Disease | GC | ||||||||||||
| Plasmablastic lymphoma | Disease | GC | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | |||||||||||
| Primary large B-cell lymphoma of immune-privileged sites | Disease | GC | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | |||||||||||
| Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | ||||||||||||
| Intravascular large B-cell lymphoma | Disease | GC | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |||||||||||
| Primary mediastinal large B-cell lymphoma | Disease | GC | ||||||||||||
| Mediastinal grey zone lymphoma | Disease | GC | ||||||||||||
| High-grade B-cell lymphoma, NOS | Disease | GC | Aiko Otsubo, PhD, Indiana University | |||||||||||
| Burkitt lymphoma | Disease | GC | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | |||||||||||
| Primary effusion lymphoma | Disease | GC | ||||||||||||
| KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
| KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | ||||||||||||
| Hyperplasias arising in immune deficiency/dysregulation | Disease | GC | ||||||||||||
| Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | GC | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | |||||||||||
| EBV-positive mucocutaneous ulcer | Disease | GC | ||||||||||||
| Lymphomas arising in immune deficiency / dysregulation | Disease | GC | ||||||||||||
| Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | GC | ||||||||||||
| Classic Hodgkin lymphoma | Disease | GC | Patricia V. Hernandez, M.D., Washington University School of Medicine | |||||||||||
| Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | ||||||||||||
| Cold agglutinin disease | Disease | SG | ||||||||||||
| IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
| Non-IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
| Monoclonal gammopathy of renal significance | Disease | SG | ||||||||||||
| Immunoglobulin-related (AL) amyloidosis | Disease | SG | Heather E. Williams, PhD, MS, PgD, ErCLG | |||||||||||
| Monoclonal immunoglobulin deposition disease | Disease | SG | Chen Yang, MD, PhD, University of Michigan | |||||||||||
| Mu heavy chain disease | Disease | SG | ||||||||||||
| Gamma heavy chain disease | Disease | SG | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | |||||||||||
| Alpha heavy chain disease | Disease | SG | ||||||||||||
| Plasmacytoma | Disease | SG | ||||||||||||
| Plasma cell myeloma / multiple myeloma | Disease | SG | *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | |||||||||||
| Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | SG | Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | |||||||||||
| CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
||||||||||||
| Kikuchi-Fujimoto disease | Disease | Sumi Kitahara (SK) | ||||||||||||
| Autoimmune lymphoproliferative syndrome | Disease | SK | ||||||||||||
| Indolent T-lymphoblastic proliferation | Disease | SK | ||||||||||||
| T-lymphoblastic leukaemia / lymphoma, NOS | Disease | HD | ||||||||||||
| Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | HD | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | |||||||||||
| T-prolymphocytic leukaemia | Disease | SK | ||||||||||||
| T-large granular lymphocytic leukaemia | Disease | SK | *Michelle Don, MD, MS | |||||||||||
| NK-large granular lymphocytic leukaemia | Disease | SK | Michelle Don, MD | |||||||||||
| Adult T-cell leukaemia/lymphoma | Disease | SK | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | |||||||||||
| Sezary syndrome | Disease | SK | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | |||||||||||
| Aggressive NK-cell leukaemia | Disease | SK | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | |||||||||||
| Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
| Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
| Mycosis fungoides | Disease | SK | Jane Scribner, MD and Daynna J. Wolff, PhD | |||||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | SK | ||||||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | SK | Theresa Spivey, MD, Shashirekha Shetty, PhD | |||||||||||
| Subcutaneous panniculitis-like T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous gamma/delta T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
| Indolent T-cell lymphoma of the gastrointestinal tract | Disease | SK | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | |||||||||||
| Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SK | ||||||||||||
| Enteropathy-associated T-cell lymphoma | Disease | SK | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | |||||||||||
| Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | SK | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | |||||||||||
| Intestinal T-cell lymphoma, NOS | Disease | SK | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | |||||||||||
| Hepatosplenic T-cell lymphoma | Disease | SK | *Michelle Don, MD, MS | |||||||||||
| ALK-positive anaplastic large cell lymphoma | Disease | SK | ||||||||||||
| ALK-negative anaplastic large cell lymphoma | Disease | SK | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | |||||||||||
| Breast implant-associated anaplastic large cell lymphoma | Disease | SK | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | |||||||||||
| Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | SK | * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG | |||||||||||
| Nodal TFH cell lymphoma, follicular-type | Disease | SK | ||||||||||||
| Nodal TFH cell lymphoma, NOS | Disease | SK | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | |||||||||||
| Peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
| EBV-positive nodal T- and NK-cell lymphoma | Disease | SK | ||||||||||||
| Extranodal NK/T-cell lymphoma | Disease | SK | ||||||||||||
| Severe mosquito bite allergy | Disease | SK | ||||||||||||
| Hydroa vacciniforme lymphoproliferative disorder | Disease | SK | ||||||||||||
| Systemic chronic active EBV disease | Disease | SK | ||||||||||||
| Systemic EBV-positive T-cell lymphoma of childhood | Disease | SK | *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | |||||||||||
| CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) |
|
|
||||||||||||
| Follicular dendritic cell sarcoma | Disease | GC | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | |||||||||||
| EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | GC | ||||||||||||
| Fibroblastic reticular cell tumour | Disease | GC | ||||||||||||
| Intranodal palisaded myofibroblastoma | Disease | GC | ||||||||||||
| Littoral cell angioma | Disease | GC | ||||||||||||
| Splenic hamartoma | Disease | GC | ||||||||||||
| Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | GC | ||||||||||||
| CHAPTER 7 (GENETIC TUMOUR SYNDROMES) |
|
|
||||||||||||
| Fanconi anaemia | Disease | NA | ||||||||||||
| Bloom syndrome | Disease | NA | ||||||||||||
| Ataxia-telangiectasia syndrome | Disease | NA | ||||||||||||
| RASopathies | Disease | NA |